期刊文献+

MACC1、c-Met在子宫内膜癌的表达和分析 被引量:2

Study of the expressions of MACC1 and c-Met in endometrial carcinoma
下载PDF
导出
摘要 目的:分析MACC1蛋白、c-Met蛋白与子宫内膜癌的关系;联合CA125分析3个因子对子宫内膜癌预后的影响.方法:采用蛋白免疫印迹方法检测MACC1、c-Met在子宫内膜癌组、子宫内膜不典型增生组、正常子宫内膜组组织中的表达变化.结果:ACC1、c-Met在子宫内膜癌组的表达均显著高于其他两组,且两者的蛋白相对表达水平与子宫内膜癌的临床分期、肌层浸润深度和淋巴结转移有关(P均<0.05);MACC1蛋白是子宫内膜癌淋巴结转移的危险因素(P<0.05),CA125是子宫内膜癌分期的危险因子(P<0.05).结论:MACC1蛋白、c-Met可能参与了子宫内膜癌的发生和侵袭、转移;MACC1联合CA125对于评估子宫内膜癌的预后更可靠. Aim:This study is to explore the correlation between MACC1 protein,c-Met protein and the development of endometrial carcinoma (EC),and to study the effects of those factors on the prognosis of EC using retrospective analysis.Methods:Tissue samples from EC group,endometrial atypical hyper-plasia group and normal endo-metrium group were collected,the expressions of MACC1 and c-Met in these samples were determined by using western blotting.Results:The protein levels of MACC1 and c-Met in tissues of endometrial cancer were significantly higher than other tissues.The expressions of MACC1 protein and c-Met protein were significantly correlated with the clinical stage,the depth of myo-metrial invasion,and Lymph node metastasis(P 〈0.05).MACC1 was a risk factor for the prognosis of EC (P 〈0.05),and CA125 was a risk factor for different stages of EC (P 〈0.05).Conclusion:The re-sults indicated that both of the two proteins may participate in the development,myometrial invasion,and metastasis of endometrial carcinoma.Joint detection for MACC1 protein and serum CA125 may be more accurate to evaluate the prognosis of EC.
出处 《暨南大学学报(自然科学与医学版)》 CAS CSCD 北大核心 2015年第6期503-508,共6页 Journal of Jinan University(Natural Science & Medicine Edition)
基金 福建省泉州市科技计划基金项目(2013Z90)
  • 相关文献

参考文献22

  • 1LI J, DOWDY S, TIPTON T, et al. HE4 as a biomarker for ovarian and endometrial cancer management [ J ]. Ex- pert Rev Mol Diagn, 2009, 9(6) : 555 -566.
  • 2谢幸,苟文丽.妇产科学[M].第8版.北京:人民卫生出版社,2013:258-264.
  • 3TRIMBLE C L, KANDEROR J, ZAINO R. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncol- ogy Group study [ J]. Cancer, 2006, 106 (4) : 812 - 819.
  • 4STEIN U, SMITH J, WALTHER W, et al. MACCI con- trois Met: what a difference an SP1 site makes [ J ]. Cell Cycle, 2009, 8 (15) : 2467 - 2469.
  • 5STEIN U, WALTHER W, ARLT F, et al. MACC1, a newly identidied key regulator of 15GF-MAT signaling, predicts colon cancer metastasis[ J]. Nat Med, 2009, 15 (1) : 59 -67.
  • 6KOKOSZYNSKA K, KRYNSKI J, RYCHLEWSKI L, et al. Unexpected domain composition of MACC1 links MET signaling and apoptosis [ J ]. Acta Biochim Pol, 2009, 56 (2) : 317 -323.
  • 7ARLT F, STEIN U. Colon Cancer metastasis: MACC1 and Met as metastatic pacemakers [ J ]. J Biochem Cell Biol, 2009, 41(12): 2356-2359.
  • 8KAWAMURA M, SAIGUSA S, TOIYAMA Y, et al. Correlation of MACC1 and MET expression in rectal canc- er after neoadjuvant chemoradiotherapy [ J ]. Anticancer Res, 2012, 32(4) : 1527 - 1531.
  • 9OTA S, SUGIYMA T, USHIJIMA K, et al. Successful treatment of two patients with recurret endometrial cancer by weekly paclitaxel[J]. Cancer Lett, 2000, 160(1) : 9 - 12.
  • 10刘清泉,刘青光,昝献峰,郭成,宋涛,姚英民.MACC1基因在肝细胞癌中的表达及临床意义[J].华中科技大学学报(医学版),2010,39(1):22-24. 被引量:19

二级参考文献74

  • 1韩世愈,贾爽,贾长茹,赵淑红.肝细胞生长因子及C-Met的表达与宫颈癌浸润和转移的关系[J].中国肿瘤临床,2006,33(21):1214-1216. 被引量:5
  • 2吴恒香,纪新强,周成军.c-Met、TIMP2与宫颈鳞癌浸润转移的相关性[J].肿瘤防治研究,2007,34(5):366-368. 被引量:3
  • 3Stein U, Walther W, Arlt F, et al. Maccl, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis[J]. Nat Med,2009,15(1):59- 67.
  • 4Birchmeier C, Birchmeier W, Gherardi E, et al. Met, metastasis, motility and more[J]. Nat Rev Mol Cell Biol, 2003,4 (12) : 915-925.
  • 5Wang R,Ferrell L D,Faouzi S,et al. Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice[J]. Cell Biol, 2001,153 (5) 1023-1034.
  • 6Bell A,Chen Q,Defrances M C,et al. The five amino acid-deleted isoform of hepatocyte growth factor promotes carcinogenesis in transgenic mice [J ]. Oneogene, 1999,18 ( 4 ) : 887- 895.
  • 7Neaud V, Faouzi S, Guirouilh J, et al. Human hepatic myofibrob lasts increase invasiveres of hepatocellular carcinoma cells:evidence for a role of hepatocyte growth factor [J]. Hepatology, 1997,26(6) : 1458-1466.
  • 8Ueki T, Fujimoto J, Suzuki T, et al. Expression of hepatocyte growth factor and its receptor c- met proto-oncogene in hepatocellular carcinoma[J]. Hepatology, 1997,25 (4) : 862-866.
  • 9O'connell J B,Maggard M A,Liu j H,et al. A report card on outcomes for surgically treated gastrointestinal cancers: are we improving? [J].J Surg Res,2004,121(2):214-221.
  • 10Danilkovitch-Miagkova A, Zbar B. Dysregulation of Met receptor tyrosine kinase activity in invasive tumors [J].J Clin Invest,2002,109(7) :863- 867.

共引文献948

同被引文献19

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部